2026 NPPES data Psychiatric/Mental Health Nurse Practitioner NPI 1851017487 DNP, FNP-BC, PMHNP-B
Verify on CMS →

CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B

Psychiatric/Mental Health Nurse Practitioner in MALVERN, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 205 beneficiaries · Psychiatric/Mental Health Nurse Practitioner avg: 927
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$115.48
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B filed 2,706 Medicare Part D claims in 2023 as a Psychiatric/Mental Health Nurse Practitioner in MALVERN, Pennsylvania, prescribing 84% generic.

3K
Part D claims, 2023
84%
generic prescribing
$115.48
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,706 Top 12% higher than 88% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B?

Quality data not reported

NPI registry status

Active

Issued 10/14/2022

NPI 1851017487

Primary specialty

Psychiatric/Mental Health Nurse Practitioner

Mid-sized

39,953 US NPIs in this specialty

Medicare Part D claims

2,706 192% vs specialty avg

2023 prescription claims

Specialty avg: 927

Specialty distribution in Pennsylvania

How Psychiatric/Mental Health Nurse Practitioner compares to other specialties among Pennsylvania providers

Pennsylvania providers

Psychiatric/Mental Health Nurse Practitioner share within Pennsylvania

1. Psychiatric/Mental Health Nurse Practitioner42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Psychiatric/Mental Health Nurse Practitioner share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Psychiatric/Mental Health Nurse Practitioner (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Psychiatric/Mental Health Nurse Practitioner ABMS/AOA estimate

Est. board-certified rate (Psychiatric/Mental Health Nurse Practitioner) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Psychiatric/Mental Health Nurse Practitioner) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B appears in the CMS NPPES registry as a Psychiatric/Mental Health Nurse Practitioner provider holding DNP, FNP-BC, PMHNP-B credentials at 101 LINDENWOOD DR STE 225, MALVERN, PA, 19355, with a listed phone of (267) 270-9582. NPI 1851017487 was issued on 10/14/2022. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AMAEFUNA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,706 prescription claims written by this provider, covering 205 Medicare beneficiaries and totaling roughly $305K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 1.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Psychiatric/Mental Health Nurse Practitioner is a mid-sized specialty nationwide, with 39,953 enrolled providers across 54 states and an average of 927 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

101 LINDENWOOD DR STE 225
MALVERN, PA 19355

Provider Details

NPI 1851017487
Specialty Psychiatric/Mental Health Nurse Practitioner
Credentials DNP, FNP-BC, PMHNP-B
Gender Female
NPI Issued 10/14/2022

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B. Source: openpaymentsdata.cms.gov.

Total received

$115

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B. To verify CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 2,706 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,706
Total Claims
$305K
Total Drug Cost
205
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,577
Total Day Supply
133,283
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$243K
Generic Drug Cost
$61K
Opioid Claims
38 (1.4% rate)
Antibiotic Claims
61

Patient Demographics

Average Patient Age
69.1 years
Avg HCC Risk Score
2.10
Gender Split
56% female / 44% male
Age Distribution
<65: 54, 65-74: 86, 75-84: 47, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
213
Albuterol Sulfate Hfa
Albuterol Sulfate
118
Amlodipine Besylate
98
Metformin Hcl
88
Gabapentin
80
Losartan Potassium
77
Lisinopril
75
Hydrochlorothiazide
70
Fluticasone Propionate
62
Omeprazole
59

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychiatric/Mental Health Nurse Practitioner Overview

How CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B fits within the Psychiatric/Mental Health Nurse Practitioner landscape nationally.

39,953
Psychiatric/Mental Health Nurse Practitioner Providers in US
54
States with Psychiatric/Mental Health Nurse Practitioner
927
Avg Claims per Provider

CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's 2,706 claims are above the specialty average of 927.

Nearby Psychiatric/Mental Health Nurse Practitioner Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as AMAEFUNA.

Compare Psychiatric/Mental Health Nurse Practitioner nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's specialty?
CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B specializes in Psychiatric/Mental Health Nurse Practitioner and practices in MALVERN, Pennsylvania. Credentials: DNP, FNP-BC, PMHNP-B.
How much does CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B prescribe under Medicare Part D?
In 2023, CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B wrote 2,706 Medicare Part D claims totaling $305K in drug costs for 205 beneficiaries.
Where is CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B located?
CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B is located at 101 LINDENWOOD DR STE 225, MALVERN, PA, 19355. Phone: (267) 270-9582.
What is CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's NPI number?
CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's National Provider Identifier (NPI) is 1851017487, issued on 10/14/2022.
Does CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B prescribe more brand-name or generic drugs?
CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's prescribing is 16% brand-name and 84% generic drugs by claim count, with $243K in brand drug costs.
Does CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B prescribe opioids?
Yes, CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B had 38 opioid claims in 2023 with an opioid prescribing rate of 1.4%.
How many Psychiatric/Mental Health Nurse Practitioner providers are there in the US?
There are 39,953 Psychiatric/Mental Health Nurse Practitioner providers across 54 states in the US. The average Psychiatric/Mental Health Nurse Practitioner provider writes 927 Medicare Part D claims per year.
What drugs does CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B prescribe most often?
Based on 2023 Medicare Part D data, CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's most frequently prescribed drugs include Atorvastatin Calcium, Albuterol Sulfate Hfa, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B accept Medicare?
CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B appears in CMS Medicare data with 2,706 Part D claims and 205 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's credentials?
CHIGOZIE AMAEFUNA, DNP, FNP-BC, PMHNP-B's NPI is 1851017487 with credentials DNP, FNP-BC, PMHNP-B. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology